Search

everythinglearnresearchcommunity

for

Search:↓

Male pattern baldness is mainly caused by a hormone called dihydrotestosterone (DHT), and drugs that can block this hormone might help prevent hair loss.

Treatment with a hormone agonist can reduce excess male hormones in postmenopausal women without surgery.

Finasteride and dutasteride may cause depression and anxiety, especially in younger men.

Certain hormone medications can treat symptoms like acne and unwanted hair, regulate periods, and prevent pregnancy in women and teenage girls.

Stiripentol shows promise as a potential treatment for androgen-related diseases but needs more testing.

Men with hair loss don't necessarily have higher levels of the hormone DHEA-S, but this hormone tends to decrease with age.

5 alpha reductase inhibitors can cause sexual, cognitive, and muscle side effects, and may slightly increase aggressive cancer risk.

Genetic defects in testosterone production can cause hormonal and developmental disorders, and more research is needed to understand androgen regulation and develop safer treatments.

5-alpha reductase inhibitors increase the risk of sexual dysfunction in patients treating enlarged prostate but not in those treating hair loss.

Anabolic steroid abuse can cause sexual, fertility, and health problems.

5-alpha reductase inhibitors may cause sexual side effects, breast complications, and other health risks in men with hair loss.

Finasteride may help reduce male hair loss and excessive hair growth by lowering DHT levels.

The document doesn't provide enough information to summarize.

The finasteride nanogel could be an effective topical treatment for hair loss.

New treatments for excessive hair growth in women, including advanced drugs and nanotechnology, show promise for better results.

Scientists made all eight versions of a compound called cyoctol, but found it's not an anti-androgen and it fully breaks down in the skin.

Masculinizing hormone therapy increases the risk of hair loss in transgender and gender-diverse patients.

Low-dose oral minoxidil improved or stabilized hair loss in some patients, but higher doses may be needed for significant effects.

Bilateral ovarian hyperthecosis is a rare but treatable cause of increased facial hair in postmenopausal women.

Clascoterone cream could be used for other skin conditions affected by hormones.

The book is a valuable reference on androgenic disorders for professionals but not suitable for laypeople or medical students.

Hirsutism involves excessive hair growth due to hormonal issues and can be treated with medication or surgery.

The document concludes that various drugs for men's health issues are in development, with treatments for sexual dysfunction and prostate conditions being the most advanced.

A woman's high testosterone levels were caused by a rare ovarian tumor, not the initially diagnosed condition.

Both treatments reduced androgen levels and hair growth in women with hirsutism.

Mohamed Kandil suggests renaming Polycystic Ovary Syndrome to "Polyfollicular Anovulatory Androgenic Syndrome" to better describe its symptoms, but concerns exist that it may not cover all related issues like obesity and depression.

5-alpha reductase inhibitors slightly increase the risk of sexual and mood side effects, and breast growth in men.

The study found no link between baldness patterns and androgen levels in men with benign prostate enlargement or prostate cancer.